BAM
CELU icon

Belpointe Asset Management’s Celularity CELU Stock Holding History

Belpointe Asset Management’s Portfolio CELU Stock Details CELU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,089
Closed -$6.75K – 1029
2023
Q1 		$6.75K Sell
1,089
-586
-35% -$4.72K ﹤0.01% 2899
2022
Q4 		$21.6K Buy
+1,675
New +$30.9K ﹤0.01% 2130

Other funds holding CELU

SIC
Starr International Company Zug, Switzerland $19.9M AUM 39.69% 1-Year Est. Return
CVSC
C.V. Starr & Co New York $187M AUM 26.03% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BFO
Biltmore Family Office Charlotte, North Carolina $761M AUM 31.91% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Belpointe Asset Management's CELU Position: Q2 2023 in Review

Belpointe Asset Management sold out of Celularity (CELU) in Q2 2023, closing a stake of 1,089 shares — an estimated $6.75K sold.

Belpointe Asset Management first reported a position in CELU in Q4 2022 and held it in 2 quarters. The position peaked at $21.6K in Q4 2022. 56 funds tracked by Wall St. Rank hold CELU as of Q2 2023.

  • Belpointe Asset Management reported no remaining Celularity position as of Q2 2023 after selling out during the quarter.
  • Belpointe Asset Management sold 1,089 Celularity shares in Q2 2023, an estimated $6.75K.
  • Belpointe Asset Management first reported a position in Celularity in Q4 2022 and held it in 2 quarters.
  • Belpointe Asset Management's Celularity position peaked at $21.6K in Q4 2022.
  • 56 funds tracked by Wall St. Rank held Celularity as of Q2 2023.

Based on Belpointe Asset Management's 13F filing for Q2 2023, filed 15 Aug 2023.